THQ vs. FBDIX

Last updated Jun 24, 2026

THQ (Abrdn Healthcare Opportunities Fund) and FBDIX (Franklin Biotechnology Discovery Fund) are both Health & Biotech Equities funds. Over the past 10 years, THQ returned 10.24%/yr vs 12.16%/yr for FBDIX. A 0.60 correlation means they provide meaningful diversification when combined. THQ charges 1.47%/yr vs 1.06%/yr for FBDIX.

Performance

THQ vs. FBDIX - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Abrdn Healthcare Opportunities Fund (THQ) and Franklin Biotechnology Discovery Fund (FBDIX). The values are adjusted to include any dividend payments, if applicable.

Returns By Period

In the year-to-date period, THQ achieves a 4.47% return, which is significantly lower than FBDIX's 10.35% return. Over the past 10 years, THQ has underperformed FBDIX with an annualized return of 10.24%, while FBDIX has yielded a comparatively higher 12.16% annualized return.

THQ

• 1D: 0.80%
• 1M: 2.93%
• YTD: 4.47%
• 6M: 5.51%
• 1Y: 19.51%
• 3Y*: 10.70%
• 5Y*: 5.26%
• 10Y*: 10.24%

FBDIX

• 1D: 3.32%
• 1M: 3.97%
• YTD: 10.35%
• 6M: 9.01%
• 1Y: 77.20%
• 3Y*: 30.39%
• 5Y*: 9.12%
• 10Y*: 12.16%

*Multi-year figures are annualized to reflect compound growth (CAGR)

THQ vs. FBDIX - Yearly Performance Comparison

	2026 (YTD)	2025	2024	2023	2022	2021	2020	2019	2018	2017
THQ Abrdn Healthcare Opportunities Fund	4.47%	13.88%	15.51%	-1.62%	-17.53%	33.39%	15.20%	22.70%	3.41%	21.84%
FBDIX Franklin Biotechnology Discovery Fund	10.35%	52.68%	15.37%	18.40%	-12.65%	-27.58%	29.85%	49.11%	-15.77%	18.83%

Correlation

The correlation between THQ and FBDIX is 0.49, which is low. Their price movements are largely independent, making them effective diversification partners.

	Correlation
Correlation (1Y) Calculated over the trailing 1-year period	0.49
Correlation (3Y) Calculated over the trailing 3-year period	0.53
Correlation (5Y) Calculated over the trailing 5-year period	0.57
Correlation (10Y) Calculated over the trailing 10-year period	0.59
Correlation (All Time) Calculated using the full available price history since Jul 29, 2014	0.60

The correlation between THQ and FBDIX shifts across timeframes, from 0.49 (1 year) to 0.60 (all time), reflecting how their relationship changes across market environments.

Return for Risk

THQ vs. FBDIX — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

THQ

THQ Risk / Return Rank: 15
THQ Sharpe Ratio Rank: 16
THQ Sortino Ratio Rank: 17
THQ Omega Ratio Rank: 16
THQ Calmar Ratio Rank: 13
THQ Martin Ratio Rank: 11

FBDIX

FBDIX Risk / Return Rank: 93
FBDIX Sharpe Ratio Rank: 96
FBDIX Sortino Ratio Rank: 90
FBDIX Omega Ratio Rank: 83
FBDIX Calmar Ratio Rank: 98
FBDIX Martin Ratio Rank: 97

The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

THQ vs. FBDIX - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Abrdn Healthcare Opportunities Fund (THQ) and Franklin Biotechnology Discovery Fund (FBDIX). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.

	THQ	FBDIX	Difference
Sharpe ratio: Return per unit of total volatility	1.07	3.25	-2.18
Sortino ratio: Return per unit of downside risk	1.61	4.11	-2.51
Omega ratio: Gain probability vs. loss probability	1.19	1.51	-0.32
Calmar ratio: Return relative to maximum drawdown	1.14	8.37	-7.24
Martin ratio: Return relative to average drawdown	3.09	26.22	-23.13

THQ vs. FBDIX - Sharpe Ratio Comparison

The current THQ Sharpe Ratio is 1.07, which is lower than the FBDIX Sharpe Ratio of 3.25. The chart below compares the historical Sharpe Ratios of THQ and FBDIX, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.

Drawdowns

THQ vs. FBDIX - Drawdown Comparison

The maximum THQ drawdown since its inception was -39.35%, smaller than the maximum FBDIX drawdown of -71.44%. Use the drawdown chart below to compare losses from any high point for THQ and FBDIX.

Drawdown Indicators

	THQ	FBDIX	Difference
Max Drawdown Largest peak-to-trough decline	-39.35%	-71.44%	+32.09%
Max Drawdown (1Y) Largest decline over 1 year	-17.25%	-9.18%	-8.07%
Max Drawdown (3Y) Largest decline over 3 years	-25.86%	-24.22%	-1.64%
Max Drawdown (5Y) Largest decline over 5 years	-32.20%	-46.83%	+14.63%
Max Drawdown (10Y) Largest decline over 10 years	-39.35%	-53.67%	+14.32%
Current Drawdown Current decline from peak	-1.11%	-0.36%	-0.75%
Average Drawdown Average peak-to-trough decline	-8.61%	-28.70%	+20.09%
Ulcer Index Depth and duration of drawdowns from previous peaks	6.33%	2.93%	+3.40%

Volatility

THQ vs. FBDIX - Volatility Comparison

The current volatility for Abrdn Healthcare Opportunities Fund (THQ) is 5.51%, while Franklin Biotechnology Discovery Fund (FBDIX) has a volatility of 8.95%. This indicates that THQ experiences smaller price fluctuations and is considered to be less risky than FBDIX based on this measure. The chart below showcases a comparison of their rolling one-month volatility.

Volatility by Period

	THQ	FBDIX	Difference
Volatility (1M) Calculated over the trailing 1-month period	5.51%	8.95%	-3.44%
Volatility (6M) Calculated over the trailing 6-month period	13.00%	18.44%	-5.44%
Volatility (1Y) Calculated over the trailing 1-year period	18.33%	23.68%	-5.35%
Volatility (5Y) Calculated over the trailing 5-year period, annualized	19.07%	25.83%	-6.76%
Volatility (10Y) Calculated over the trailing 10-year period, annualized	20.49%	26.35%	-5.86%

THQ vs. FBDIX - Expense Ratio Comparison

THQ has a 1.47% expense ratio, which is higher than FBDIX's 1.06% expense ratio.

Dividends

THQ vs. FBDIX - Dividend Comparison

THQ's dividend yield for the trailing twelve months is around 11.45%, more than FBDIX's 9.80% yield.

Position	TTM	2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015
FBDIX Franklin Biotechnology Discovery Fund	9.80%	10.81%	19.53%	0.00%	0.13%	0.98%	14.50%	18.77%	3.72%	2.39%	4.57%	8.42%
THQ Abrdn Healthcare Opportunities Fund	11.45%	11.29%	11.09%	7.45%	6.81%	5.27%	6.62%	7.08%	8.05%	7.71%	8.70%	9.50%

Frequently Asked Questions

Can I hold both THQ and FBDIX in my portfolio?

THQ and FBDIX have a correlation of 0.49, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

Which is riskier, THQ or FBDIX?

FBDIX has higher volatility (8.95%) compared to THQ (5.51%). In terms of maximum drawdown, THQ dropped -39.35% vs FBDIX's -71.44%.

Which has better risk-adjusted returns?

FBDIX currently has the higher Sharpe Ratio (3.25 vs 1.07), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.